At higher concentrations of 5-10 mg/kg, as well as at daily dosing protocols of 0.5-2.8 mg/kg, which are normally well tolerated in dogs, milbemycin oxime provoked neurological toxicity in MDR1 mutant dogs including ataxia, salivation and depression [84,99]. This evidence concerns the gene ABCB1 and depressive disorder.